Mycobacterium bovis BCG-Russia clinical isolate with noncanonical spoligotyping profile

Journal of Clinical Microbiology

Volumn 48, Issue 12, 2010, Pages 4686-4687

  Mokrousov, Igor ^a   Vyazovaya, Anna ^a   Potapova, Yulia ^b   Vishnevsky, Boris ^b   Otten, Tatiana ^b   Narvskaya, Olga ^a  

^a ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^b ST PETERSBURG RESEARCH INSTITUTE OF PHTHISIOPULMONOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BCG VACCINE; ISONIAZID; RIFAMPICIN;

BACTERIAL STRAIN; BACTERIUM ISOLATE; BCG VACCINATION; HUMAN; LETTER; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RUSSIAN FEDERATION;

CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; HUMANS; INFANT; MALE; MOLECULAR TYPING; MYCOBACTERIUM BOVIS; RUSSIA; TUBERCULOSIS;

MYCOBACTERIUM BOVIS BCG;

EID: 78650070890     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01368-10     Document Type: Letter

References (17)

1. Aksyonova, V. A., D. T. Levi, E. V. Fonina, and N. N. Vundzettel. 2009. Vaccinoprophylaxis of tuberculosis: importance and problems. Probl. Tuberk. Bolezn. Legk. 2009(1):10-16. (In Russian.)
2. Azzopardi, P., C. M. Bennett, S. M. Graham, and T. Duke. 2009. Bacille Calmette-Guérin vaccine-related disease in HIV-infected children: a systematic review. Int. J. Tuber. Lung Dis. 13:1331-1344.
3. Behr, M. A., and P. M. Small. 1999. A historical and molecular phylogeny of BCG strains. Vaccine 17:915-922.
4. Benjamin, W. H., Jr., K. H. Lok, R. Harris, N. Brook, L. Bond, D. Mulcahy, N. Robinson, V. Pruitt, D. P. Kirkpatrick, M. E. Kimerling, and N. E. Dunlap. 2001. Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype. J. Clin. Microbiol. 39:1092-1096.
5. Boniotti, M. B., M. Goria, D. Loda, A. Garrone, A. Benedetto, A. Mondo, E. Tisato, M. Zanoni, S. Zoppi, A. Dondo, S. Tagliabue, S. Bonora, G. Zanardi, and M. L. Pacciarini. 2009. Molecular typing of Mycobacterium bovis strains isolated in Italy from 2000 to 2006 and evaluation of variable-number tandem repeats for geographically optimized genotyping. J. Clin. Microbiol. 47:636-644.
6. Grant, A., C. Arnold, N. Thorne, S. Gharbia, and A. Underwood. 2008. Mathematical modelling of Mycobacterium tuberculosis VNTR loci estimates a very slow mutation rate for the repeats. J. Mol. Evol. 66:565-574.
7. Keller, P. M., E. C. Böttger, and P. Sander. 2008. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant. BMC Microbiol. 8:120.
8. Lari, N., N. Bimbi, L. Rindi, E. Tortoli, and C. Garzelli. 22 September 2010. Genetic diversity of human isolates of Mycobacterium bovis assessed by spoligotyping and variable number tandem repeat genotyping. Infect. Genet. Evol. [Epub ahead of print.] doi:10.1016/j.meegid.2010.09.004.
9. Luciani, F., S. A. Sisson, H. Jiang, A. R. Francis, and M. M. Tanaka. 2009. The epidemiological fitness cost of drug resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 106:14711-14715.
10. Mahairas, G. G., P. J. Sabo, M. J. Hickey, D. C. Singh, and C. K. Stover. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-1282.
11. Pym, A. S., P. Brodin, R. Brosch, M. Huerre, and S. T. Cole. 2002. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46:709-717.
12. Ritz, N., and N. Curtis. 2009. Mapping the global use of different BCG vaccine strains. Tuberculosis (Edinb.) 89:248-251.
13. Roring, S., A. N. Scott, R. Glyn Hewinson, S. D. Neill, and R. A. Skuce. 2004. Evaluation of variable number tandem repeat (VNTR) loci in molecular typing of Mycobacterium bovis isolates from Ireland. Vet. Microbiol. 101:65-73.
14. Rosenberg, N. A., A. G. Tsolaki, and M. M. Tanaka. 2003. Estimating change rates of genetic markers using serial samples: applications to the transposon IS6110 in Mycobacterium tuberculosis. Theor. Popul. Biol. 63:347-363.
15. Schürch, A. C., K. Kremer, A. Kiers, O. Daviena, M. J. Boeree, R. J. Siezen, N. H. Smith, and D. van Soolingen. 2010. The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale. Infect. Genet. Evol. 10:108-114.
16. Supply, P., S. Lesjean, E. Savine, K. Kremer, D. van Soolingen, and C. Locht. 2001. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol. 39:3563-3571.
17. Wirth, T., F. Hildebrand, C. Allix-Béguec, F. Wölbeling, T. Kubica, K. Kremer, D. van Soolingen, S. Rüsch-Gerdes, C. Locht, S. Brisse, A. Meyer, P. Supply, and S. Niemann. 2008. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 4:e1000160.